"The voice for cancer physicians and their patients in Massachusetts."
The U.S. Food and Drug Administration approved ravulizumab-owvz (Ultomiris; Alexion Pharmaceuticals, Inc.) for adult patients with paroxysmal nocturnal hemoglobinuria (PNH). Read full press release.
Massachusetts Society of Clinical Oncologists (c) 860 Winter Street, Waltham, MA. 02451
Waltham, MA. 02451